Cochrane · systematic review · CD008216

Autologous hematopoietic stem cell transplantation following high‐dose chemotherapy for nonrhabdomyosarcoma soft tissue sarcomas

Peinemann, F, Enk, H, Smith, LA · Cochrane Database of Systematic Reviews · 2017 · Cochrane Library

Gynaecological, Neuro-oncology and Orphan Cancer2 versionsAMSTAR 2: not assessed

SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.

Questions

current version

GRADE rated

No studies

Included studies

No studies 3 · 50%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 3 · 50%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Show all 2 versions

Autologous hematopoietic stem cell transplantation following high‐dose chemotherapy for nonrhabdomyosarcoma soft tissue sarcoma

Population: people with non‐rhabdomyosarcoma soft tissue sarcoma

6 questions

Outcome	Effect	Evidence	Status / GRADE
Overall survival	HR 1.26 [0.7, 2.29]	1 study · 83 participants	High
Treatment‐related mortality	no estimate extracted	1 study · 83 participants	High
Disease‐free survival	no estimate extracted	NR	No studies
Progression‐free survival	HR 1.34 [0.81, 2.2]	1 study · 83 participants	High
Non‐hematologic toxicity grade 3 to 4	no estimate extracted	NR	No studies
Health‐related quality of life	no estimate extracted	NR	No studies